Benzinga's Top Pre-Market Gainers
Envivio (NASDAQ: ENVI) shares jumped 26.79% to $3.55 in pre-market trading after the company reported Q2 results.
Pozen (NASDAQ: POZN) shares gained 14.56% to $6.06 in the pre-market session after the company signed a licensing agreement with Sanofi's (NYSE: SNY) US unit for the marketing of PA8140 and PA32540 tablets in the US.
Groupon (NASDAQ: GRPN) soared 6.27% to $10.94 in the pre-market trading. Analysts at Morgan Stanley upgraded Groupon to “overweight.”
Astex Pharmaceuticals (NASDAQ: ASTX) surged 4.11% to $8.61 in the pre-market session after Otsuka Pharmaceutical announced its plans to buy the company for $8.50 per share in cash.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.